Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective In Vitro Diagnostic Clinical Performance Study for an Influenza A+B Point-of-Care Test Kit on Patients Exhibiting Influenza-like Illness

NCT03895268 is registered in ClinicalTrials.gov with Sanwa BioTech Limited as lead sponsor.

NCT NCT03895268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03895268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective In Vitro Diagnostic Clinical Performance Study for an Influenza A+B Point-of-Care Test Kit on Patients Exhibiting Influenza-like Illness
Lead sponsor
Sanwa BioTech Limited
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2022
Completion date
February 28, 2023
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza type a, influenza type b